ESAB Corporation ESAB 深 沪
已收盘 04-02 16:00:00 美东时间
98.37
-2.530
-2.51%
华盛通- 最 高100.64
- 今 开96.65
- 成交量 115.03万股
- 最 低 96.0396
- 昨 收 100.90
- 总市值 59.89亿
- 52周最高 137.32
- 市盈率 静 26.72
- 换手率 0.00%
- 52周最低 89.31
- 委 比 85.71%
- 总股本 6088.15万
- 历史最高 137.32
- 量 比 1.24
- 振 幅 4.56%
- 历史最低 31.06
- 每 手 1
- 风险率 8.83%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多ESAB announces CFO transition
ESAB (ESAB) announced R. Brent Jones has been appointed CFO, effective early May 2026. Mr. Jones succeeds Kevin Johnson, who is leaving ESAB to pursue a CFO opportunity at a privately held company. K...
04-02 19:02
ESAB names R. Brent Jones CFO, replacing Kevin Johnson in May 2026
ESAB names R. Brent Jones CFO, replacing Kevin Johnson in May 2026 ESAB appointed R. Brent Jones as chief financial officer, effective early May 2026. Jones previously served as CFO at Pall Corp, most recently at Avantor. Kevin Johnson will leave ESAB to take a CFO role at a privately held company.
04-02 18:30
ESAB Issues Senior Notes to Fund Eddyfi Acquisition
The latest announcement is out from ESAB Corporation ( ($ESAB) ). On March 26, ...
03-27 04:54
Royce Small-Cap Trust (NYSE: RVT) as of Jan 31, 2026
Oldest and largest small-cap closed-end fund Average weekly trading volume of approximately 2,313,377 shares Fund's adviser has more than 50 years of small- and micro-cap investment experien...
02-28 02:01
美股大行评级 | 大摩将康宁目标价从103美元升至127美元；潜在涨幅1779.7%！IGC Pharma获Ascendiant Capital升目标价至5美元
今日重点评级关注：Ascendiant Capital：维持IGC Pharma"买入"评级，目标价从4.75美元升至5美元；Brookline Capital：维持C4 Therapeutics"买入"评级，目标价从20美元升至30美元
02-24 10:27
Stifel Maintains Buy on ESAB, Raises Price Target to $158
Stifel analyst Nathan Jones maintains ESAB (NYSE:ESAB) with a Buy and raises the price target from $144 to $158.
02-23 23:11
ESAB Affirms FY2026 Adj EPS Guidance of $5.70-$5.90 vs $5.94 Est
ESAB (NYSE:ESAB) affirms FY2026 Adj EPS guidance from $5.70-$5.90 to $5.70-$5.90 vs $5.94 analyst estimate..
02-20 21:29
ESAB Q4 Adj. EPS $1.35 Beats $1.34 Estimate, Sales $720.986M Beat $687.768M Estimate
ESAB (NYSE:ESAB) reported quarterly earnings of $1.35 per share which beat the analyst consensus estimate of $1.34 by 0.75 percent. This is a 5.47 percent increase over earnings of $1.28 per share from the same period
02-20 21:29
Insights into ESAB Q4 Earnings
The Q4 earnings report for ESAB (NYSE:ESAB) was released on Friday, February 20...
02-20 21:28
财报速睇 | ESAB Corporation 2025财年Q4营收7.21亿美元，同比增长7.5%；归母净利润0.38亿美元，同比下滑29.9%
华盛资讯2月20日讯，ESAB Corporation公布2025财年Q4业绩，公司Q4营收7.21亿美元，同比增长7.5%，归母净利润0.38亿美元，同比下滑29.9%。
02-20 20:02
